Medicure (MCUJF) Gains from Investment Securities (2010 - 2026)

Medicure's Gains from Investment Securities history runs 11 years deep, the most recent figure standing at $117402.1 for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 443.79% year-over-year to $117402.1; the TTM figure through Mar 2026 stood at $4936.1 (up 104.13% YoY), while the FY2025 annual figure was -$129075.5, down 1.87% from the prior year.
• Gains from Investment Securities was $117402.1 for Q1 2026 at Medicure, down from $369299.4 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $391386.0 in Q2 2022 to a low of -$744807.3 in Q2 2025.
• Historically, Gains from Investment Securities has averaged $45082.5 across 5 years, with a median of $32414.9 in 2022.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities surged 2102.52% in 2024, then slumped 580.52% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at $32414.9 in 2022, then sank by 61.48% to $12487.1 in 2023, then sank by 375.17% to -$34360.8 in 2024, then jumped by 1174.77% to $369299.4 in 2025, then sank by 68.21% to $117402.1 in 2026.
• The last three Gains from Investment Securities figures came in at $117402.1 (Q1 2026), $369299.4 (Q4 2025), and $263041.9 (Q3 2025), per Business Quant data.